Addition of a Loop Diuretic to Norepinephrine During Treatment of Hepatorenal Syndrome Type 1
In patients with HRS-1 who are adequately treated with norepinephrine and achieved an optimal MAP increment, addition of i.v. furosemide enhances diuresis without negatively affecting renal recovery.
Authors
- Terrance J. Wickman (ORCID: https://orcid.org/0000-0003-2372-9227)
- Ivo Lukitsch
- Catherine Wentowski (ORCID: https://orcid.org/0009-0003-5178-0000)
- Swetha Rani Kanduri (ORCID: https://orcid.org/0000-0002-7190-6665)
- Kasra Tayebi (ORCID: https://orcid.org/0000-0001-8678-3795)
- Adil Yousuf
- Muner Mohamed (ORCID: https://orcid.org/0000-0001-6437-8457)
- Derek J. Vonderhaar
- Karthik Kovvuru (ORCID: https://orcid.org/0000-0003-2640-724X)
- Juan Carlos Q. Velez
Institutions
- Ochsner Health System (US)
- The University of Queensland (AU)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.013
- Citations
- 2
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- American Society of Nephrology
- Ochsner Health